Narrative review / 2020
Current evidence on the safety and efficacy of low-calorie and non-calorie sweeteners remains scarce and controversial.
This narrative review summarizes current evidence regarding the neuroendocrine and metabolic effects of low- and non-calorie sweeteners, including their impact on the central nervous system, gut hormones, and gut microbiota. While sweeteners may help reduce calorie intake and prevent weight gain, studies examining their short- and long-term safety and efficacy are scarce and controversial. The authors note the need for future studies to elucidate beneficial and detrimental effects across healthy populations and those with metabolic disorders, and discuss sweetener use in very-low calorie ketogenic diets.
- Study type
- Narrative review
- Who was studied
- Healthy subjects and patients with diabetes, obesity, and metabolic syndrome
- What was measured
- Neuroendocrine, metabolic effects, energy balance, appetite, body weight, and gut microbiota
THE PAPER
Neuroendocrine and Metabolic Effects of Low-Calorie and Non-Calorie Sweeteners.
Moriconi E, Feraco A, Marzolla V, Infante M, Lombardo M, Fabbri A, Caprio M. Front Endocrinol (Lausanne), 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.